glutathione and triple negative breast cancer Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven metalloimmunotherapy for triple-negative | Journal of Nanobiotechnology Oncology Letters
Oncology Letters Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple negative breast cancer treatment ScienceDirect Glutathione Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor Positive Triple Negative Breast Cancer ACS Nano Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy: Cell Metabolism Metabolic reprogramming in triple negative breast cancer Cancer Biology & Medicine Frontiers Ferroptosis: the emerging player in remodeling triple negative breast cancer
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





